DK366589A - Humant protein c-mutant, dens fremstilling og dna, som koder derfor - Google Patents

Humant protein c-mutant, dens fremstilling og dna, som koder derfor Download PDF

Info

Publication number
DK366589A
DK366589A DK366589A DK366589A DK366589A DK 366589 A DK366589 A DK 366589A DK 366589 A DK366589 A DK 366589A DK 366589 A DK366589 A DK 366589A DK 366589 A DK366589 A DK 366589A
Authority
DK
Denmark
Prior art keywords
humant
mutant
protein
manufacturing
dna coding
Prior art date
Application number
DK366589A
Other languages
English (en)
Other versions
DK366589D0 (da
Inventor
Tamotsu Hashimoto
Masahiro Sato
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of DK366589D0 publication Critical patent/DK366589D0/da
Publication of DK366589A publication Critical patent/DK366589A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DK366589A 1988-07-26 1989-07-25 Humant protein c-mutant, dens fremstilling og dna, som koder derfor DK366589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18453888 1988-07-26

Publications (2)

Publication Number Publication Date
DK366589D0 DK366589D0 (da) 1989-07-25
DK366589A true DK366589A (da) 1990-01-27

Family

ID=16154955

Family Applications (1)

Application Number Title Priority Date Filing Date
DK366589A DK366589A (da) 1988-07-26 1989-07-25 Humant protein c-mutant, dens fremstilling og dna, som koder derfor

Country Status (8)

Country Link
EP (1) EP0352651A1 (da)
JP (1) JP2728240B2 (da)
KR (1) KR910003095A (da)
AU (1) AU3890689A (da)
DK (1) DK366589A (da)
FI (1) FI893545A7 (da)
IE (1) IE892412L (da)
PT (1) PT91268A (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE163048T1 (de) * 1989-12-29 1998-02-15 Zymogenetics Inc Hybrides protein c
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
IL97311A0 (en) * 1990-02-23 1992-05-25 Lilly Co Eli Vectors and compounds for expression of glycosylation mutants of human protein c
US20010006967A1 (en) * 1992-09-21 2001-07-05 Stanley M. Crain Method of simultaneously enhancing analgesic potency and attenuating adverse side effects caused by tramadol and other bimodally-acting opioid agonists
SV1999000067A (es) * 1998-06-01 2000-07-06 Lilly Co Eli Proteina humana c polipeptida ref. x-12279
CA2391651A1 (en) * 1999-11-19 2001-05-25 Eli Lilly And Company Protein c derivatives
KR100576180B1 (ko) * 2002-07-27 2006-05-03 주식회사 한화 비폭발성 에멀젼 조성물
AU2003280316A1 (en) * 2002-11-11 2004-06-03 Maxygen Aps Zymogen-like protein c polypeptides
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
KR102744525B1 (ko) * 2021-12-29 2024-12-18 주식회사 한화 저비중 에멀젼 폭약 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341228C (en) * 1985-06-27 2001-05-15 Mark J. Murray Expression of protein c
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
FI882746L (fi) * 1987-06-12 1988-12-13 Hoechst Japan Hybridprotein c och foerfarande foer dess framstaellning.

Also Published As

Publication number Publication date
JPH02167096A (ja) 1990-06-27
AU3890689A (en) 1990-02-01
PT91268A (pt) 1990-02-08
FI893545A0 (fi) 1989-07-24
FI893545L (fi) 1990-01-27
KR910003095A (ko) 1991-02-26
EP0352651A1 (en) 1990-01-31
JP2728240B2 (ja) 1998-03-18
FI893545A7 (fi) 1990-01-27
DK366589D0 (da) 1989-07-25
IE892412L (en) 1990-01-26

Similar Documents

Publication Publication Date Title
NO892834D0 (no) Imidoperoksikarboksylsyrer, dens fremstilling og anvendelse.
NO891061D0 (no) Podet a-mono-olefin-kopolymer, dens fremstilling og anvendelse.
DK656189A (da) Stabiliseret sucralosekompleks, dets fremstilling og anvendelse
NO905334D0 (no) Selektive katalysatorer og fremstilling derav.
FI962247A7 (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden kä yttömenetelmät
DK122687D0 (da) Polypeptid, dna og anvendelse deraf
DE3688321D1 (de) Entspannungsventil.
NO882858L (no) Silikapartikler, fremstilling og anvendelse derav.
DK366589A (da) Humant protein c-mutant, dens fremstilling og dna, som koder derfor
FI906443A7 (fi) DNA, joka koodaa A-tyypin humaanimonoamiinioksidaasia
DK212789A (da) Utvaerbundet hydrogel, dens fremstilling og anvendelse
FI902803A7 (fi) DNA-sekvenssi, joka koodaa a-amylaasi-pullulanaasientsyymiä
FI893450L (fi) Modifierade proteiner.
DK151788A (da) Hybridserpiner og dna, som koder derfor
FI891308A7 (fi) Uudet polypeptidit, joilla on kasvutekijäaktiivisuutta sekä polypeptideitä koodittavat nukleiinihapposekvenssit
NO885687D0 (no) Opploeselig rekombinant fcepsilon - reseptor, fremstilling og anvendelse derav.
DE3888715D1 (de) Reg-Gen und dadurch kodiertes Protein.
DK125087D0 (da) Efomycin g., dets fremstilling og anvendelse
FI892254A0 (fi) Anvaendning av a-aminoboronsyraderivat foer stabilisering av peptid- och proteinlaekemedel.
FI891977A0 (fi) Redoxaktiva centra.
FI873674A7 (fi) --2-plasmiini-inhibiittorin kaltaista proteiinia koodaava DNA.
DK661389A (da) Dna-sekvens, som koder for placentaspecifikt protein pp11, dens isolering og anvendelse
NO894821D0 (no) Homopolysakkarid, opploesning derav, og deres fremstillingog anvendelse.
DK72091A (da) Superledende sammensaetning, dens fremstilling og anvendelse
NO893698L (no) 2,3,4,5-tetrahydro-1-benzoksepiner, fremstilling og anvendelse derav.

Legal Events

Date Code Title Description
ATS Application withdrawn